BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2009
View Archived Issues
Reduced fractures with denosumab in postmenopausal women and men with prostate cancer
Read More
Studies with HC-056456 reveal CatSper channels as a target for blocking fertility
Read More
rAAV1-AAT gene therapy shows promise for future development in phase I trial
Read More
Doxorubicin derivative INNO-206 more potent than free doxorubicin in vivo
Read More
Merck & Co. to assess safety/efficacy of MK-2578 in kidney disease patients in phase II trial
Read More
Safety and efficacy of JTT-130 to be evaluated in obese type 2 diabetic patients
Read More
Bayer relegates clinical trials for alemtuzumab to Genzyme Japan
Read More
Bevacizumab plus erlotinib therapy shows activity in phase II clinical trial in HCC
Read More
Can-Fite BioPharma reports results from its phase II CF-101 trial in psoriasis
Read More
Opexa Therapeutics reports additional data with Tovaxin for multiple sclerosis
Read More
Novel PARP inhibitors presented by AstraZeneca for cancer therapy
Read More
R-Tech Ueno presents VAP-1 inhibitors for macular edema and other eye conditions
Read More
Akela undergoes corporate restructuring
Read More
PPARgamma agonists for the treatment of AD described by GlaxoSmithKline
Read More
Panacea Biotec discloses DPP-IV inhibitors for the treatment of type 2 diabetes
Read More
NeuroSearch patents novel dopamine and serotonin receptor ligands as antipsychotics
Read More
Luminex receives 510(k) clearance for new cystic fibrosis test
Read More
XenoPort reports results from a safety and tolerability trial of arbaclofen
Read More
LigoCyte initiates phase I/II study of nasally delivered dry powder norovirus vaccine
Read More
Shire provides update on velaglucerase alfa for Gaucher's disease
Read More
GlycoMimetics begins pilot study of GMI-1070 in sickle cell patients
Read More
Dor BioPharma receives NIH grant to support phase I/II DOR-201 trial in radiation enteritis
Read More
Evotec commences phase I trial of EVT-103
Read More
Ark Therapeutics receives feedback from MHRA on EG-013
Read More
Bayer Schering submits IND for phase I MN-IC trial, triggering milestone payments
Read More